All Achievements
activity Clinical examination of the skin
activity Clinical examination of the skin, skin cancer, dermatitis, acne, psoriasis, drug reactions
activity Clinical examination of the skin, skin cancer, dermatitis, acne, psoriasis, drug reactions
activity "Plenary Session speaker - Immunoregulation of T cell lymphoma using T cell receptor peptides”
activity Vaccination against aggressive murine T cell lymphoma
activity Identification of tumor-specific cutaneous T cell lymphoma peptides
activity Increased loading of immunogenic peptides on dendritic cells to enhance tumor immunity
activity Cytotoxic T lymphocytes recognize synthetic T cell receptor-derived major histocompatibility complex class I peptides from a murine CD4 T cell clone
activity Tumor specific antigens on the malignant cells of cutaneous T cell lymphoma are derived from clone specific T cell receptor chains
activity 8-Methoxypsoralen/UVA enhanced expression of empty MHC class I H-2Kb molecules on RMA cells
activity Coculture of supernatant from RMA cells treated with 8-methoxypsoralen/UVA induces an increase in MHC class I expression on untreated cells
activity Treatment with 8-methoxypsoralen (8-MOP)/UVA increases MHC class II expression on human monocytes
activity Quantitation of a major histocompatibility complex class I molecule after 8- methoxypsoralen and UVA photoinduction
activity Purification and sequence analysis of murine major histocompatibility complex class I self-peptides
activity A murine T-cell lymphoma model showing protection against tumor development and treatment of established disease
activity A murine T-cell lymphoma model showing protection against tumor development and treatment of established disease
activity Isolation and sequence analysis of murine MHC class I antigenic peptides
activity Elution of MHC class I antigenic peptides from the murine B lymphoma LB27.4